Verastem reported $-21.3M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
AbbVie USD 3.69B 1.68B Mar/2026
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
AstraZeneca USD 5.16B 510M Jun/2026
Curis USD -12.3M 231K Sep/2023
Cytokinetics USD -169.32M 19.48M Mar/2026
Gilead Sciences USD 3.51B 489M Mar/2026
Incyte USD 778.57M 410.6M Jun/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
Novartis USD 6.48B 1.19B Jun/2026
Pfizer USD 5.99B 5.23B Mar/2026
Roche Holding CHF 13.43B 744M Jun/2026
TG Therapeutics USD 28.11M 23.58M Mar/2026